Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study
Titel:
Epirubicin–cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study
Auteur:
Pico, C. Martin, M. Jara, C. Barnadas, A. Pelegri, A. Balil, A. Camps, C. Frau, A. Rodriguez-Lescure, A. Lopez-Vega, J.M. de la Haba, J. Tres, A. Alvarez, I. Alba, E. Arcusa, A. Oltra, A. Batista, N. Checa, T. Perez-Carrion, R. Curto, J.